United States · FDA National Drug Code directory
MiraLAX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55154-5035_a30d3776-09c8-41aa-9282-ba2486632e07
- Product NDC
- 55154-5035
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Polyethylene Glycol 3350
- Labeler
- Cardinal Health 107, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20090223
- Source listing expiry
- 20261231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 17 g/17g
These values do not establish equivalence or a dose recommendation.
Packages
- 6 PACKET in 1 BAG (55154-5035-6) / 17 g in 1 PACKET · 55154-5035-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →